General Information of Drug (ID: DMP7JBR)

Drug Name
Dendritic cancer cell vaccine
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 1 [1]
Cross-matching ID
TTD ID
D0Y0RF

References

1 Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015 May 15;348(6236):803-8.